AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25897797
Drug: Prodromal Detection
RxNorm normalized name: alpha tocopherol / ascorbic acid / cholecalciferol / docosahexaenoic acid / docusate sodium / ferrous fumarate / folic acid / pyridoxine hydrochloride / tricalcium phosphate Oral Capsule [Nexa Select]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prodromal Detection and Treatment program (including information campaigns and detection teams)
Trial: 20889164
Drug: Succimer chelation
RxNorm normalized name: Succimer
DrugBank: Succimer (DB00566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Succimer chelation treatment
Trial: 18336963
Drug: Twinrix vaccine
RxNorm normalized name: TWINRIX vaccine 1 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twinrix vaccine administered according to a 0-, 1-, and 6-month schedule.
Trial: 16464519
Drug: Atorvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (40 mg for 10 days)
Trial: 11737908
Drug: Short-term infusion
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term infusion of corticosteroids
Trial: 8477564
Drug: MS Contin
RxNorm normalized name: MS Contin
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MS Contin tablets 90 mg
Trial: 8477564
Drug: Oramorph SR
RxNorm normalized name: Oramorph SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oramorph SR tablets 30 mg
Trial: 8477564
Drug: Oramorph SR
RxNorm normalized name: Oramorph SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oramorph SR tablets 90 mg
Trial: 8477564
Drug: MS Contin
RxNorm normalized name: MS Contin
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MS Contin tablets 30 mg
Trial: 8477564
Drug: MS Contin
RxNorm normalized name: MS Contin
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MS Contin tablets
Trial: 8477564
Drug: Oramorph SR
RxNorm normalized name: Oramorph SR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oramorph SR tablets
Trial: 21504886
Drug: Tobacco dependence
RxNorm normalized name: Tobacco leaf
DrugBank: Tobacco leaf (DB10710)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tobacco dependence treatment RCT incorporating behavioral counseling and nicotine replacement
Trial: 17698902
Drug: Growth Hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth Hormone (GH) 4 IU subcutaneously every other day for 3 months
Trial: 12536693
Drug: Buflomedil 100
RxNorm normalized name: buflomedil
DrugBank: Buflomedil (DB13510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buflomedil 100 mg.d‐1
Trial: 9270084
Drug: Systemic alpha1-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic alpha1-receptor blockade (BLK)
Trial: 3301710
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg femoxetine daily for 16 weeks
Trial: 3301710
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily for 16 weeks
Trial: 3301710
Drug: Femoxetine in
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Femoxetine in subgroups of patients previously in anorectic treatment
Trial: 31617649
Drug: Crocin (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crocin (two capsules per day for 28 days)
Trial: 31617649
Drug: Placebo (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (two capsules per day for 28 days)
Trial: 25629740
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg of subcutaneous icatibant
Trial: 25629740
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (intravenous prednisolone 500 mg plus clemastine 2 mg)
Trial: 30139568
Drug: Phonophoresis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phonophoresis with diclofenac + Thiocolchicoside gel (Group 1)
Trial: 30139568
Drug: Ultrasound therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound therapy with non-therapeutic gel (Group 2)
Trial: 20029243
Drug: Zaltoprofen 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zaltoprofen 80 mg
Trial: 18700222
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg intravenous diamorphine
Trial: 18700222
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg subcutaneous hydromorphone
Trial: 16251561
Drug: Halothane 2,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halothane 2, 4, and 6 mL
Trial: 16251561
Drug: Sevoflurane 5
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane 5 mL
Trial: 16251561
Drug: Halothane 1
RxNorm normalized name: halothane 1000 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Halothane 1 mL, Isoflurane 1.5 mL, Sevoflurane 2.7 mL
Trial: 12717749
Drug: Test didanosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test didanosine formulation (200 mg)
Trial: 12717749
Drug: Reference didanosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference didanosine formulation (200 mg)
Trial: 1594257
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment group (n = 31)
Trial: 25956588
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (E2) 50 to 200 mcg/day
Trial: 22233155
Drug: Nabilone (1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone (1, 2 or 3 mg)
Trial: 18272031
Drug: Sunitinib as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunitinib as maintenance therapy
Trial: 8355383
Drug: Prehospital-initiated treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prehospital-initiated treatment (aspirin and alteplase)
Trial: 8355383
Drug: Hospital-initiated treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital-initiated treatment (aspirin and alteplase)
Trial: 8355383
Drug: Treatment initiated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment initiated within 70 minutes of symptom onset (both prehospital and hospital)
Trial: 3657877
Drug: Pneumococcus vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcus vaccine (control)
Trial: 2477300
Drug: Contact endoscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contact endoscopic laser treatment
Trial: 2477300
Drug: Noncontact endoscopic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noncontact endoscopic laser treatment
Trial: 31354810
Drug: Calcium and
RxNorm normalized name: Calcium and Magnesium
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium and vitamin D supplements
Trial: 23574590
Drug: Drospirenone (DRSP)
RxNorm normalized name: Drospirenone
DrugBank: Drospirenone (DB01395)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Drospirenone (DRSP) with ethinyl-estradiol 20 μg (DRSP/EE20)
Trial: 23574590
Drug: Drospirenone (DRSP)
RxNorm normalized name: Drospirenone
DrugBank: Drospirenone (DB01395)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Drospirenone (DRSP) with ethinyl-estradiol 30 μg (DRSP/EE30)
Trial: 11385059
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (250 IU d-alpha tocopherol 3 times daily for 1 year)
Trial: 8338977
Drug: 1,25-(OH)2D 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,25-(OH)2D 0.5 microgram/day + trichlormethiazide (TZ) 2 mg/day for 4 weeks
Trial: 8338977
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment with combined 1,25-(OH)2D and TZ for 11-29 months
Trial: 17645559
Drug: Caiapo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caiapo (4 g daily for 5 months)
Trial: 10910310
Drug: Omeprazole sodium,
RxNorm normalized name: Esomeprazole Sodium, 20 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole sodium, 20 mg once daily
Trial: 9263160
Drug: morphine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: morphine (0.3 mg/kg)
Trial: 9263160
Drug: lidocaine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lidocaine (5 mg/kg)
Trial: 9263160
Drug: ketamine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ketamine (0.3 mg/kg)
Trial: 3307623
Drug: Oral ribavirin
RxNorm normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral ribavirin treatment
Trial: 31296264
Drug: Innovative and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Innovative and stepped structural case management program for depression treatment in nursing home residents.
Trial: 27836532
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care plus 20 jumps twice daily
Trial: 21319341
Drug: Diacerein treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diacerein treatment group (n = 12)
Trial: 20015431
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose Yunchang Capsule (0.35 g/pill, 2 pills + 1 simulant pill, three times daily)
Trial: 20015431
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Yunchang Capsule (0.35 g/pill, 3 pills, three times daily)
Trial: 20015431
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Biantong Capsule, 0.35 g/pill, 3 pills, three times daily)
Trial: 20015431
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose Yunchang Capsule
Trial: 20015431
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Yunchang Capsule
Trial: 20015431
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Biantong Capsule)
Trial: 16428355
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml sterile water as placebo (group 1, n = 10)
Trial: 16428355
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml 33% sucrose solution (group 2, n = 10)
Trial: 16428355
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml sterile water with pacifier (group 3, n = 9)
Trial: 16428355
Drug: 1 ml
RxNorm normalized name: ethanol 1 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 ml 33% sucrose solution with pacifier (group 4, n = 11)
Trial: 12847731
Drug: Pollen immunotherapy
RxNorm normalized name: Pollen immunotherapy extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pollen immunotherapy
Trial: 12847731
Drug: Low‐molecular‐weight allergen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low‐molecular‐weight allergen peptide vaccines
Trial: 17563272
Drug: Clopidogrel loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel loading dose of 300 mg 6-24 hours before intervention and maintenance for 1 month
Trial: 17563272
Drug: Clopidogrel treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel treatment continued for at least 24 months
Trial: 17563272
Drug: Clopidogrel treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel treatment after 6 months from bare-metal stenting
Trial: 9707350
Drug: Fludrocortisone (Florinef)
RxNorm normalized name: fludrocortisone acetate Oral Tablet [Florinef]
DrugBank: Fludrocortisone (DB00687)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fludrocortisone (Florinef) therapy for orthostatic hypotension
Trial: 9707350
Drug: No fludrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No fludrocortisone therapy
Trial: 9200279
Drug: 150‐mg ranitidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150‐mg ranitidine effervescent tablets
Trial: 9200279
Drug: 20‐mg famotidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20‐mg famotidine wafers
Trial: 2293218
Drug: ACC-9653 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACC-9653 administered alone
Trial: 2293218
Drug: ACC-9653 administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACC-9653 administered concomitantly with diazepam
Trial: 2293218
Drug: ACC-9653 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACC-9653 and diazepam administered together
Trial: 7271345
Drug: Methylprednisolone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (1 g in operating room plus 3,578 mg average during the next three days)
Trial: 27550954
Drug: Crushed immediate-release
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed immediate-release oxycodone 40 mg
Trial: 27550954
Drug: Crushed ALO-02
RxNorm normalized name: miconazole nitrate 0.02 MG/MG [Aloe Vesta Antifungal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed ALO-02 40 mg/4.8 mg
Trial: 27550954
Drug: Crushed ALO-02
RxNorm normalized name: miconazole nitrate 0.02 MG/MG [Aloe Vesta Antifungal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crushed ALO-02 60 mg/7.2 mg
Trial: 27550954
Drug: Intact ALO-02
RxNorm normalized name: miconazole nitrate 0.02 MG/MG [Aloe Vesta Antifungal]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intact ALO-02 60 mg/7.2 mg
Trial: 26093827
Drug: Deferasirox (DEFR)
RxNorm normalized name: Deferasirox
DrugBank: Deferasirox (DB01609)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Deferasirox (DEFR) administered BID (40 mg/kg)
Trial: 26093827
Drug: Deferasirox (DEFR)
RxNorm normalized name: Deferasirox
DrugBank: Deferasirox (DB01609)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Deferasirox (DEFR) administered once daily (30 or 40 mg/kg)
Trial: 22686074
Drug: Integrative medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Integrative medicine (IM) treatment for diabetic nephropathy
Trial: 20151768
Drug: Inhaled human
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled human insulin (Exubera) titrated once weekly
Trial: 20151768
Drug: Inhaled human
RxNorm normalized name: insulin, regular, human Inhalation Powder [Afrezza]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled human insulin (Exubera) titrated twice weekly
Trial: 16222890
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg tamsulosin once daily orally (n = 40)
Trial: 16222890
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg alfuzosin once daily orally (n = 36)
Trial: 10102945
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg b.d., clarithromycin 500 mg b.d., amoxycillin 1 g b.d.
Trial: 10102945
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg b.d., clarithromycin 500 mg b.d., amoxycillin 1 g b.d.
Trial: 10102945
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg b.d., clarithromycin 500 mg b.d., amoxycillin 1 g b.d.
Trial: 10102945
Drug: Ranitidine bismuth
RxNorm normalized name: RANITIDINE BISMUTH CITRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine bismuth citrate 400 mg b.d., tetracycline 500 mg t.d.s., tinidazole 500 mg b.d.
Trial: 7757313
Drug: Antipyrine powder
RxNorm normalized name: Antipyrine
DrugBank: Antipyrine (DB01435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine powder (1,050 mg)
Trial: 7757313
Drug: Antipyrine capsule
RxNorm normalized name: Antipyrine
DrugBank: Antipyrine (DB01435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine capsule (1,050 mg)
Trial: 7757313
Drug: Antipyrine powder
RxNorm normalized name: Antipyrine
DrugBank: Antipyrine (DB01435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine powder and capsule formulations
Trial: 7757313
Drug: Antipyrine capsule
RxNorm normalized name: Antipyrine
DrugBank: Antipyrine (DB01435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipyrine capsule formulation
Trial: 37697
Drug: Clopimozide (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopimozide (average optimum daily dose of 13.95 mg)
Trial: 30074112
Drug: Ticagrelor combined
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor combined with aspirin
Trial: 11124134
Drug: Triglyceride (Intralipid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triglyceride (Intralipid 20%, 1.5 ml/min) and heparin (bolus: 200 IU; constant infusion rate: 0.2 IU.kg(‐1).min(‐1))
Trial: 10381989
Drug: Ipratropium with
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium with beta-agonists
Trial: 24338756
Drug: Conventional Colonoscopy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Colonoscopy (CC)
Trial: 24074299
Drug: Online psychological
RxNorm normalized name: FILTER,SUCTION,INLINE #FHBF200S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Online psychological treatment
Trial: 2574555
Drug: Hydroxyzine, 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine, 25 mg qid
Trial: 21269305
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no oral antibiotics for 4 weeks)
Trial: 18185995
Drug: KEEP (Keeping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KEEP (Keeping Foster Parents Trained and Supported) based on Multidimensional Treatment Foster Care (MTFC)
Trial: 16877984
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg) combined with IV propofol (0.5 mg/kg)
Trial: 16877984
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam combined with IV propofol
Trial: 10966534
Drug: D-Dimer level
RxNorm normalized name: dimer dilinoleyl dimer dilinoleate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-Dimer level >500 microg/L
Trial: 8941062
Drug: 2.5 mg/d
RxNorm normalized name: Androderm 2.5 MG/Day 24 HR Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg/d MPA plus 0.625 mg/d conjugated estrogens (group A: 31 patients)
Trial: 8941062
Drug: 0.625 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.625 mg/d estrone sulfate (group B: 28 patients)
Trial: 1609752
Drug: 1.4 mg
RxNorm normalized name: phenol 1.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.4 mg Zn/d
Trial: 1609752
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg Zn/d
Trial: 1609752
Drug: 3.4 mg
RxNorm normalized name: urea 83.4 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.4 mg Zn/d
Trial: 1609752
Drug: 10.4 mg
RxNorm normalized name: cisapride 10.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.4 mg Zn/d
Trial: 31468596
Drug: Lycopene 25
RxNorm normalized name: lycopene 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene 25 mg
Trial: 29167971
Drug: Abaloparatide-SC 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abaloparatide-SC 20 μg
Trial: 29167971
Drug: Abaloparatide-SC 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abaloparatide-SC 40 μg
Trial: 29167971
Drug: Abaloparatide-SC 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abaloparatide-SC 80 μg
Trial: 29167971
Drug: Subcutaneous teriparatide
RxNorm normalized name: Teriparatide
DrugBank: Teriparatide (DB06285)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Subcutaneous teriparatide 20 μg
Trial: 23756850
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (prednisolone + lamivudine)
Trial: 23756850
Drug: Monotherapy (prednisolone)
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy (prednisolone)
Trial: 22040285
Drug: Acceptance and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acceptance and Commitment Therapy (ACT) intervention consisting of three 2-hr group sessions scheduled during a single week.
Trial: 20227241
Drug: web‐based therapist‐assisted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: web‐based therapist‐assisted cognitive behavioral treatment (web‐CBT)
Trial: 17765381
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of dimenhydrinate
Trial: 12512792
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment protocol as defined by consensus among acupuncture trainers
Trial: 10329342
Drug: 30 minutes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 minutes of brisk walking in any combination of bouts (minimum 5 minutes each)
Trial: 1742749
Drug: L-threonine 4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-threonine 4.5 g/day
Trial: 1742749
Drug: L-threonine 6.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-threonine 6.0 g/day